Catherine Parry
Catherine Parry
Business Development Director – CTS
Jamie Beaumont
Jamie Beaumont
Executive Director Clinical Trial Sourcing
COREX at World Vaccine Congress Europe 2026

Jamie Beaumont and Catherine Parry from COREX will be attending World Vaccine Congress Europe 2026 in Amsterdam and are looking forward to connecting with organisations across the vaccine supply chain.

From clinical development and manufacturing through to supply, logistics and global access, the vaccine landscape presents increasingly complex sourcing and distribution challenges. This event brings together organisations working across this entire value chain, making it an ideal opportunity for COREX to connect with potential partners and discuss practical solutions to the sourcing, supply and access challenges facing the vaccine sector.

Our expertise includes, but is not limited to:
  • Supporting clinical development with specialist sourcing of vaccines and other complex-to-source pharmaceutical products, with supply solutions tailored to programme requirements.
  • Cold-Chain Storage & Logistics, providing specialist storage and logistics solutions for vaccines and temperature-sensitive products, including ultra-low temperature requirements, to maintain product integrity throughout the supply chain.
  • Developing tailored supply solutions to facilitate access to medicines and vaccines in complex markets where specialist knowledge and flexible solutions are essential.

We are keen to engage with vaccine manufacturers, suppliers, distributors, healthcare organisations, clinical development teams and other organisations working across the vaccine ecosystem.

If you are looking to source vaccines or pharmaceutical products, strengthen your supply chain, navigate a complex market, support a clinical programme or explore new distribution opportunities, we would welcome the opportunity to discuss your requirements.
Arrange a meeting at World Vaccine Congress Europe.

COREX
Specialist pharmaceutical supply, access and logistics for vaccines across global markets.

Back to the list